AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Ghadessy, FJ Ong, JL Holliger, P
Citation: Fj. Ghadessy et al., Directed evolution of polymerase function by compartmentalized self-replication, P NAS US, 98(8), 2001, pp. 4552-4557

Authors: Bonino, O Dugne, O Merlet, C Gat, E Holliger, P Lahaye, M
Citation: O. Bonino et al., Study of surface modification of uranium and UFe2 by various surface analysis techniques, J NUCL MAT, 294(3), 2001, pp. 305-314

Authors: Tomlinson, I Holliger, P
Citation: I. Tomlinson et P. Holliger, Methods for generating multivalent and bispecific antibody fragments, METH ENZYM, 326, 2000, pp. 461-479

Authors: Holliger, P Bohlen, H
Citation: P. Holliger et H. Bohlen, Engineering antibodies for the clinic, CANC METAST, 18(4), 1999, pp. 411-419

Authors: Gilet, P Chenevas-Paule, A Duvaut, P Grenouillet, L Holliger, P Million, A Rolland, G Vannuffel, C
Citation: P. Gilet et al., Growth and characterization of thick GaAsN epilayers and GaInNAs/GaAs multiquantum wells, PHYS ST S-A, 176(1), 1999, pp. 279-283

Authors: Holliger, P Riechmann, L Williams, RL
Citation: P. Holliger et al., Crystal structure of the two N-terminal domains of g3p from filamentous phage fd at 1.9 angstrom: Evidence for conformational lability, J MOL BIOL, 288(4), 1999, pp. 649-657

Authors: Manzke, O Fitzgerald, KJ Holliger, P Klock, J Span, M Fleischmann, B Hescheler, J Liu, QH Johnson, KS Diehl, V Hoogenboom, HR Bohlen, H
Citation: O. Manzke et al., CD3x anti-nitrophenyl bispecific diabodies: Universal immunotherapeutic tools for retargeting T cells to tumors, INT J CANC, 82(5), 1999, pp. 700-708

Authors: Hidaka, H Holliger, P Gauthier-Lafaye, F
Citation: H. Hidaka et al., Tc/Ru fractionation in the Oklo and Bangombe natural fission reactors, Gabon, CHEM GEOL, 155(3-4), 1999, pp. 323-333

Authors: Holliger, P Manzke, O Span, M Hawkins, R Fleischmann, B Liu, QH Wolf, J Diehl, V Cochet, O Winter, G Bohlen, H
Citation: P. Holliger et al., Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins, CANCER RES, 59(12), 1999, pp. 2909-2916
Risultati: 1-9 |